Cell migration requires precise coordination of many signaling pathways to achieve directed motility. We report here that NIH3T3 fibroblasts expressing a dominant negative PKA subunit (dnPKA) show diminished migration in response to serum or growth factors. This effect is not a general effect on cell motility, but rather a decreased capacity to enhance migration in response to stimuli. Control (neo) and dnPKA cells show very similar haptotactic migration toward fibronectin, but dnPKA cells show reduced stimulation of migration in response to EGF/PDGF or serum. These effects were not due to alterations in cell growth or adhesion to fibronectin. Forskolin, which elevates cyclic adenosine monophosphate (cAMP) levels, dramatically inhibited neo cell motility in a scrape migration assay, although dnPKA cell migration was unaffected. The MEK selective inhibitor U0126 and the phosphatidyl-inositol-3 kinase (PI3K) inhibitor LY294002 inhibited migrating neo cells and were able to further inhibit residual dnPKA cell migration. Our data show that intermediate or well-controlled levels of PKA activity are required for optimal growth factor-stimulated migration in fibroblasts. PKA may play an important role in the signaling processes that lead to motility.
INTRODUCTION
Migration is an important process involved in development, wound healing, angiogenesis, and tumor metastasis. During migration cells are required to spatially coordinate polarization, adhesion to the substratum, and actin polymerization to move the membrane in the direction of migration. The Rho family of small GTPases, which include Cdc42, Rac1, and RhoA, mediates many cytoskeletal effects [1] . Growth factors such as platelet-derived growth factor (PDGF) activate Cdc42 and Rac to induce the filopodial and lamellipodial protrusions crucial to cell motility. RhoA and its downstream effectors are involved in maintaining focal contacts and contractile stress fibers in adherent cells [2] . Myosin light chain (MLC) phosphorylation, which enhances contractility, is downstream from both RhoA [3] and extracellular-regulated kinase (ERK). Abolition of ERK activity reduces this contractility and cell migration [4] .
The effects of elevated levels of cAMP on migration and the cytoskeleton have been widely studied [5] [6] [7] [8] [9] . Several agents can be used to activate cAMP signaling within the cell. The actions of forskolin, 1-isobutylmethylxanthene (IBMX), or cell-permeable cAMP analogs such as dibuteryl cAMP release catalytic protein kinase-A (PKA) from regulatory subunits within the cell [10, 11] . In many cell types, high cAMP levels have countermigratory effects [9, 12, 13] . Strong activation of cAMP-dependent signaling can affect migration through a number of potential effects. PKA can impinge on ERK activity through inactivation of Raf [14, 15] or loss of cytoskeletal integrity. PKA phosphorylation on Ser188 inhibits RhoA and its subsequent downstream effector ROK␣ to alter cell morphology. These morphological effects can be counteracted by the RhoA activator thrombin, or an activated RhoA that is mutant in its Ser188 PKA phosphorylation site [7] . Finally, PKA may impinge on cytoskeletal integrity through modulation of vasodilator-simulated phosphoprotein (VASP) [16, 17] , actin depolymerizing factor (ADF)/cofillin [18] , or p-21-activated kinase (PAK) [19] .
In this work, we investigated the migration of NIH3T3 fibroblasts stably expressing dominant negative PKA (dnPKA) regulatory subunits. The results of our study show that PKA inhibition has no effect on haptotactic mobility toward fibronectin. However, stimulated migration is inhibited by dnPKA in both transwell and wound scrape assays. Both the MEK inhibitor U0126 and the PI3K inhibitor LY294002 block control NIH3T3 (neo) cell migration and the residual dnPKA cell migration. Thus, PKA appears to play an important role in enhancing migration in response to extracellular stimuli.
MATERIALS AND METHODS
Cell culture. NIH3T3 cells selected for an empty vector control (neo), or dnPKA expression, were obtained from Alan Howe (University of North Carolina at Chapel Hill, NC). The dnPKA used is an RII regulatory subunit triple point mutation [20] that does not bind cAMP and efficiently inhibits PKA activation. Both cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) (Sigma, St. Louis, MO) supplemented to 10% fetal bovine serum (Sigma) and 2 mg/ml G418 (Sigma). Human recombinant epidermal growth factor (EGF) and PDGF were from Upstate Biotechnology (Lake Placid, NY). Myristoylated PKI (14 -22) (BioMol, Plymouth Meeting, PA), U0126 (Calbiochem, San Diego, CA), LY294002 (Calbiochem), forskolin, and aphidicolin (Sigma) were maintained as stock solutions in dimethyl sulfoxide (DMSO) (Fisher, Fair Lawn, NY) at Ϫ20°C.
Scrape migration assays. Six-well plates (Costar, Corning, NY) were coated overnight with 10 g/ml fibronectin (BD Biosciences, Bedford, MA) in phosphate-buffered saline (PBS) and blocked with 1% bovine serum albumin (BSA) (Sigma) in DMEM. Neo and dnPKA cells were suspended with 0.05% trypsin/5.3 mM ethylenediaminetetraacetic acid (EDTA) (GIBCO, Grand Island, NY) and trypsin was blocked with 1 g/ml soybean trypsin inhibitor (GIBCO). Cells were counted and 5 ϫ 10 5 cells per well were plated in serumfree DMEM for 3 h, during which time cells were also treated with applicable inhibitors or DMSO. Monolayer cultures were then wounded with a P-200 pipette tip and medium was replaced with DMEM/5% FBS/2 mg/ml G418 and pharmacological agents. Cells were photographed at 20ϫ adjacent to a reference line etched on the bottom of the plate. Cells were allowed to grow and migrate for 24 h at 37°C in 5% CO 2 before being photographed a second time. For experiments where cell replication was inhibited, cells were plated and maintained in the presence of 1 g/ml aphidicolin. For experiments using forskolin, U0126, and LY294002, DMSO levels were adjusted to be equal in all wells within each experiment and were never higher than 0.5% DMSO. Each experiment was performed in triplicate and repeated three to five times.
Quantification of cell migration. Photographs from scrape migrations were captured and analyzed using Scion Image v4.0.2 (Scion Corp., Frederick, MD). Two hundred-microliter pipette tip scrapes correlate to a 200 ϫ 640 pixel area. Such areas were selected from time 0 and 24-h pictures and copied to new files. Images were inverted, thresholded to eliminated background, and converted to binary (black and white) form, and an integrated density measurement was performed. In essence, this method allowed the quantification of the amount of bright white refraction that accompanies the perimeter of each cell within the scrape area. Time 0 numbers were subtracted from 24-h calculations to provide a net migration into the wound. For each experiment, the mean of neo, untreated cell migration was set to 100%. All other means were adjusted accordingly. From three to six scrapes per treatment group were analyzed for each experiment. Two to eight experiments were analyzed for quantification.
Transwell migration assay. Twelve-well polycarbonate transwell migration chambers containing 12-m pores (Costar) were coated on the underside with 500 l of 20 g/ml fibronectin in PBS for 2 h at 37°C. Wells were washed three times with PBS and replaced with 1.5 ml serum-free DMEM, DMEM containing 2 g/ml PDGF and 5 g/ml EGF, or DMEM with 10% FBS. Cells were serum starved for 4 h, harvested with trypsin/EDTA, washed, and resuspended in DMEM containing 1% BSA. Cells (10 5 ) in 500 l of 1% BSA were added to the top of the transwell chamber. Cells were allowed to migrate for 20 h. Cells remaining on top of the well were removed with a sterile cotton swab; cells migrating through the membrane were fixed and stained with DiffQuick staining kit (Dade Behring, Newark, DE). Each experiment was performed in triplicate wells. Each well was photographed at four distinct sites and stained cells were counted. Statistical significance was determined by paired t test on Microsoft Excel (Redmond, WA).
Western blotting. ERK and AKT phosphorylation were analyzed in cells after 24-h migrations. Cells were washed with PBS, lysed directly into Laemmli sample buffer, separated on 10% SDS-polyacrylamide gels, and transferred to polyvinyldiflouride (PVDF) membranes (Millipore, Bedford, MA). Membranes were incubated with phospho-ERK monoclonal antibody (Promega) and horseradish peroxidase-linked anti-mouse IgG secondary antibody (Calbiochem) and detected with enhanced chemiluminescence (ECL) (Amersham). Blocking and antibody incubations were carried out in PBS containing 0.1% Tween-20 (Sigma) and 1% BSA. Membranes were stripped for 30 min at 55°C in 62.5 mM Tris, pH 6.8/2% SDS/0.75% 2-mercaptoethanol and similarly reprobed with a rabbit polyclonal total ERK Ab, sc-94 (Santa Cruz Biotechnology, Santa Cruz, CA). Akt was assayed similarly using rabbit polyclonal antibodies to phosphoserine 308 Akt, phospho-serine 473 Akt, or a c-terminal fragment of Akt (New England Biolabs, Beverly, MA) and ECL detection. cAMPresponse-element-binding protein (CREB) and phospho-Ser133-CREB polyclonal Abs (New England Biolabs) were used to analyze cells that had been serum-starved for 8 h, treated with 25 M forskolin for 30 min, and lysed directly into Laemmli sample buffer.
Cell adhesion assays. Ninety-six-well plates were coated with 100 l 2 g/ml or 20 g/ml fibronectin in PBS for 2 h at 37°C and then washed three times with PBS. Neo and dnPKA cells were detached with trypsin/EDTA, washed, and resuspended in DMEM/1% BSA. Cells (5 ϫ 10 4 ) in 100 l DMEM/1% BSA were plated into each well. Cells were allowed to adhere for up to 30 min at 37°C. Adhesive strength was compared using methods previously described [21] . Briefly, cells were allowed to adhere for 1 h and wells were filled to the point of a positive meniscus, covered with platesealing tape, inverted, and centrifuged for 10 min at 1000g in a swinging bucket rotor. Adherent cells were quantified after washing three times with PBS. Cells were fixed and stained with 0.5% crystal violet (wt/v) (Sigma) in 20% methanol/PBS (v/v) for 15 min at room temperature. Wells were washed with water, crystal violet was solubilized, (30 min in 200 l 10 mM Tris, pH 6.8), and absorbance was read at 540 nm. Each data point represents an average of eight wells.
Cell growth assays. Neo and dnPKA cells were harvested as above and plated, serum free, into 24-well plates precoated with 20 g/ml fibronectin in PBS. Cells were allowed to adhere for 3 h before treatment with DMEM containing 10% serum or 2 g/ml PDGF and 5 g/ml EGF. Cell number was determined with an Elzone 80H cell counter (Particle Data, Elmhurst, IL) from three wells for each data point at 0, 10, 20, 44, and 74 h.
RESULTS

DnPKA Expression Inhibits Migration in a Wound Assay
NIH3T3 cells previously selected in G418 for expression of dnPKA subunits or a control plasmid (neo) were used. DnPKA cells show diminished PKA activity as seen by lack of CREB phosphorylation in response to forskolin (Fig. 1) . DnPKA cells have also been shown to lack PKA activity in response to de-adhesion [19] and fail to cause a PKA-dependent mobility shift in VASP in response to forskolin compared to neo cells (data not shown). In 24-h scrape migration assays, dnPKA cells showed reduced closure of a wounded monolayer compared to neo cells (Fig. 2, Table 1 ). Figure 2A shows migration performed on 10 g/ml fibronectin and in 5% FBS. Similar results were obtained on tissue culture plastic without pretreatment, or on 1, 10, or 100 g/ml fibronectin, and in 5 or 10% FBS (data not shown). Neither cell line displayed significant motility in serum-free or 0.5% FBS conditions (data not shown). Similar to what has been shown previously [9, 12] , neo cell migration is significantly inhibited by forskolin. Recent studies reveal that cAMP can signal through non-PKA pathways, such as activation of Rap1 by Epacs [22] or ligand-gated ion channels [23] . However, up to 50 M forskolin had little effect on dnPKA cell migration ( Fig. 2A) , implying that forskolin-mediated inhibition of migration requires PKA activity. These effects can also be replicated by pharmacological abrogation of PKA of wild-type NIH3T3 cells. Treatment with cell-penetrating myristoylated PKI (mPKI) also diminished scrape wound migration compared to DMSO-treated controls (Fig. 2B) . Scrape migrations were also performed in the presence of the DNA synthesis inhibitor aphidicolin to rule out possible confounding differences due to cell replication. Figure 2C shows that neo cells migrated into the wound more quickly than dnPKA cells even in the absence of cell division.
Reduced Chemotaxis in DnPKA Cells
Migration was evaluated and quantified by transwell assays. Migration stimulated by a gradient of EGF and PDGF was significantly reduced in cells where PKA activity is blocked (Fig. 3, P Ͻ 0.01) . Similar results were obtained using NIH3T3 cells inhibited with mPKI (not shown). DnPKA cells also show reduced chemotaxis toward 10% FBS (Fig. 3) . Interestingly, both cell lines are identical in haptotactic mobility, as evidenced by their similar migration in the absence of growth factors. These data imply that dnPKA expression does not affect basal levels of cytoskeleton remodeling or motility in unstimulated conditions. However, dnPKA cells are less capable of engaging in chemotaxis in response to growth factors. These observed differences in migration do not appear to be a result of differences in cell adhesion or replication. Because alterations in cell adhesion have been shown to affect migratory speed [24] , we tested for differences in dnPKA adhesion to fibronectin. However, both cell lines adhere similarly to surfaces coated with fibronectin and had similar adhesive strength. Neo and dnPKA cells adhered similarly to a range of fibronectin concentrations after 30 min (Fig. 4A) . Both cell lines showed a similar rate of adhesion to a 2 or 20 g/ml coating of fibronectin over time (Fig. 4B) . Neo and dnPKA cells also show no detectible differences in adhesive strength when plated onto fibronectin and centrifuged inverted at 1000g (Fig. 4C) . Another possible explanation for apparent differences in transwell or wound migration could have been differences of cell replication rates. However, neo and dnPKA cells displayed similar growth rates when plated on fibronectin and exposed to either EGF/PDGF or 5% FBS (Fig. 4D) .
ERK Activity in Migrating neo and dnPKA Cells
PKA activity can block efficient activation of ERK, which is essential for migration. Therefore, we investigated the ERK phosphorylation status in cell lysates after 24 h of migration. We conclude that the primary inhibition of migration by forskolin appears not to be due to inhibition of ERK pathways. ERK activation in neo cells was unaffected at 10 M forskolin (Fig. 5) , a level that clearly inhibited migration in these cells (Fig. 2 ). This conclusion is also supported by the data in Fig. 6 , which show that neo cell migration is near normal even at U0126 levels (1-3 M) that dramatically inhibit ERK. Surprisingly, ERK activation in dnPKA cells was found to be highly elevated after prolonged treatment with forskolin despite total ERK levels that were somewhat downregulated (Fig. 5) . Recently, it has been shown that forskolin treatment inhibits ERK phosphorylation in NIH3T3 cells through Rap1 in a PKA-dependent manner [15] . Treatment of fibroblasts with forskolin while PKA is inhibited (through the use of H89 [15] , or in dnPKA cells) leads to prolonged ERK activation (Fig. 5 and data not  shown) .
Effects of Pharmacological Inhibitors on Migration
Because the defect in dnPKA migration appeared to be a loss in the ability to sense or transmit signals from growth factors to the migration machinery, several pharmacological inhibitors were used to assess the inhibition of signaling pathways on migration in these cells. The MEK selective inhibitor U0126 inhibited migration in both cell lines at a concentration of 10 M and showed a more dramatic effect at 30 M (Fig. 6 ). This effect was clear in control cells. DnPKA cells show diminished migration into a wound, and U0126 concentration of 10 and 30 M further inhibited any residual capacity for migration. Inhibition of migration by U0126 in both cells lines requires nearly complete abolishment of ERK activity as measured by phospho-ERK antibodies (Fig. 7) . U0126 inhibits both cell lines with a similar dose response, which implies that the ERK pathway contribution to migration is likely not affected by dnPKA expression.
Neo and dnPKA cells also remained sensitive to inhibition by the PI3K selective inhibitor LY294002. Neo cells begin to show inhibition of migration at 1 M with increasing inhibition at 5 and 20 M LY294002 (Fig.   8 ). The residual migration of dnPKA could also be slowed by PI3K inhibition. The effectiveness of the LY294002 was measured by looking at alterations in phosphorylation of serine 308 of Akt, a PDK1 target that is downstream of phosphoinositide production. At first glance, Akt phosphorylation appears unaffected (Fig. 9, top panel) . Total Akt protein is greatly upregulated in both neo and dnPKA in response to LY294002, but the amount of p308-Akt is constant; thus the ratio of p308-Akt to total Akt diminishes in LY294002-treated cells. Interestingly, the non-PI3K-related serine 473 site of Akt shows hyperphosphorylation at levels in line with Akt overexpression (Fig. 9) .
FIG. 2. (A)
Neo and dnPKA NIH3T3 fibroblast migration in a wound healing assay; 5 ϫ 10 5 cells were plated serum-free into six-well plates coated with 10 g/ml fibronectin. Cell monolayers were wounded with a P-200 pipette tip and treated with vehicle (DMSO), or 10 or 50 M forskolin in 5% FBS. Wells were photographed at 0 and 24 h adjacent to a reference line scraped on the bottom of the plate. (B) NIH3T3 cells were treated with vehicle (DMSO) or 2 M mPKI and assayed for scrape wound healing as above. (C) Neo and dnPKA cells were pretreated for 3 h with 1 g/ml aphidicolin prior to wounding the monolayer. Cells were allowed to migrate for 24 h in the presence of 10% FBS and 1 g/ml aphidicolin.
DISCUSSION
Our data show that optimal migration requires PKA activity. Many chemoattractants elevate cAMP during migration [25] , either directly or secondary to changes in cell shape [26] , although there is a narrow range for which this increase is stimulatory for migration [12, 13] . The regulation of these cAMP levels is very complex. There are at least 10 known adenyl cyclase isoforms and over 30 phosphodiesterase isoforms that could allow for spatial and temporal regulation of cAMP [11] . PKA activity is further regulated by localization, as PKA holoenzymes are anchored to A kinase anchoring proteins (AKAPs) and AKAP-like proteins within the cell. Recent findings show that the wiscottaldrich syndrome protein (WASP) family protein WAVE, which scaffolds Rho family proteins to actin polymerizing machinery, acts as an AKAP which could localize PKA to sites just behind the leading edge of migrating cells [27] . PKA localization and activity may be precisely controlled to provide important signals for migration.
This hypothesis is consistent with findings in our lab showing that dnPKA cells maintain efficient EGF signaling to ERK in suspension. This effect correlates with dnPKA cell maintenance of FAK and paxillin phosphorylation in suspension. Both of these effects are reversed by incubation with the actin depolymerizing agent cytochalasin D [19] . These data suggest that dnPKA cells maintain higher levels of F-actin after de-adhesion, which may help maintain the integrity of important signaling complexes. The reduced capacity to breakdown and remodel actin may be one cause of dnPKA inhibition of migration.
However, several facts lead us to believe that dnPKA impairment of motility likely involves the signaling that leads to migration rather than just structural effects on actin. DnPKA cells have normal haptotactic responses, but altered response to chemotactic stimulation. These data are in agreement with other observations using pharmacological inhibitors of PKA activ- 
FIG. 3.
DnPKA migration is inhibited in transwell assay. Neo and dnPKA cells were plated into the top chamber of modified Boyden chambers containing 12-m pores. Cells were allowed to migrate for 20 h toward 20 g/ml fibronectin coating and serum-free DMEM (s) or media containing EGF and PDGF (s) (left). In a separate series of experiments, neo and dnPKA cells migrated for 20 h toward 20 g/ml fibronectin coating and serum-free DMEM (s) or media containing 10% FBS (s) (right). Graphs represent an average of at least three independent experiments. Error bars denote standard deviations. *P Ͻ 0.01. ity [6] . H89 inhibition of PKA activity has no effect on haptotactic migration of HUVECs toward vitronectin [28] while several adenyl cyclase inhibitors block endothelin-stimulated migration of neutrophils [8] . This may also agree with EGF stimulation of calpain activation, which requires PKA and helps release the trailing edge of migrating cells [29] .
Our data suggest that inhibition of migration by forskolin is primarily due to PKA-mediated effects. While forskolin could activate alternate pathways such as Rap1 and cAMP-gated ion channels in neo and dnPKA cells, elevation of cAMP had little effect on migration in the dnPKA cells. Therefore, the cAMP effects that inhibit migration require activation of PKA. In addition, our use of U0126 reveals that a high degree of ERK inhibition is required to significantly affect NIH3T3 migration. The fact that forskolin inhibits migration at levels that still allow for efficient activation of the ERK pathway means that PKA must primarily impinge on migration through other effectors.
Our data do not discern whether dnPKA cells are slower in overall motility or lack the ability to maintain directional migration. There are several lines of evidence which suggest that PKA may be involved with directional motility. Dictostelium cells lacking PKA function are less accurate in phototaxis, the ability to orient polarity with regard to light [30] . More recent findings reveal that elevated cAMP activates cdc42 in a PKA-dependent manner [31] ; activated cdc42 is believed to help maintain cell polarity [1] .
These data show that cAMP and PKA act as both positive and negative regulators of migration in fibroblasts. Complete abolishment or overstimulation of PKA activity is inhibitory while intermediate levels of PKA activity support cell migration. That PKA activity is particularly important for stimulated migration reveals a role for PKA in allowing cells to optimally sense their growth factor environment or in affecting the dynamic modulation of actin that is required for migration. Considering the many layers of control of cAMP levels and PKA localization, it seems likely that precise temporal or spatial activation of PKA is crucial for cell motility. 
FIG. 9.
Akt phosphorylation in neo and dnPKA cells migrating in the PI3K inhibitor LY294002. Cell lysates from neo and dnPKA cells photographed in Fig. 8 were harvested after 24 h of migration in the presence of 0, 1, 5, or 20 M LY294002; lysate proteins were separated by 10% SDS-PAGE and probed for p308-Akt, p473-Akt, and total Akt.
